Mayo Clinic Board of Trustees elects Matthew R. Callstrom, M.D., Ph.D., as next president and CEO
Article excerpt
Highlighted: the sentence this signal was extracted from
ROCHESTER, Minn., Nov. 13, 2026 /PRNewswire/ -- The Mayo Clinic Board of Trustees announced today that it has elected Matthew R. Callstrom, M.D., Ph.D., to succeed Gianrico Farrugia, M.D., as president and CEO of Mayo Clinic. Dr. Farrugia will remain president and CEO through December 31, 2026, working closely with Dr. Callstrom to ensure a seamless transition. "Dr. Callstrom is an accomplished physician-scientist and enterprise leader who brings nearly 25 years of experience at Mayo Clinic and a deep commitment to our values and mission," says Richard K. Davis, chair, Mayo Clinic Board of Trustees. "His leadership across patient care, research, strategy and innovation, combined with his ability to translate scientific discovery and emerging technology into meaningful advances for patients, prepares him exceptionally well to lead Mayo Clinic into its next chapter." Dr. Callstrom joined Mayo Clinic in 2002 and has held leadership roles spanning clinical practice, research, strategy, AI and innovation. A member of Mayo Clinic's Board of Governors and Board of Trustees, he serves as medical director for Mayo Clinic Strategy and the AI Program and previously served as interim chief strategy officer and chair of the Department of Radiology at Mayo Clinic in Rochester. Across these roles, he has helped shape Mayo Clinic's organizational strategy and advance the responsible...
Keep reading with a free account
The rest of this article, and every signal for Mayo Clinic, is in your free account.
